Other postmarketing reports

CurrencyCurrent through May 31, 2023
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
1 cases
  • In re Incretin-Based Therapies Prods. Liab. Litig.
    • United States
    • U.S. District Court — Southern District of California
    • November 9, 2015
    ...have an ongoing duty to report the results of studies and drug surveillance to the FDA. 21 U.S.C. § 355(k)(1) ; 21 C.F.R. §§ 314.80, 314.81 ; Dobbs, 797 F.Supp.2d at 1270 ("After a drug is approved by the FDA, manufacturers are required to maintain records, conduct additional testing as dir......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT